Fortress Biotech, Inc. (FBIO) Other Assets, Noncurrent USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Fortress Biotech, Inc. quarterly Other Assets, Noncurrent history and growth rate from 2012 to 2024.
  • Fortress Biotech, Inc. Other Assets, Noncurrent for the quarter ending March 31, 2024 was $3.97 M, a 321% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $3.97 M +$3.03 M +321% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.28 M +$3.31 M +340% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 $4.82 M +$3.43 M +246% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.57 M +$2.41 M +206% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $943 K -$129 K -12% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $973 K -$225 K -18.8% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.39 M -$314 K -18.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.17 M +$41 K +3.64% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.07 M -$49 K -4.37% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.2 M +$185 K +18.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.71 M +$352 K +26% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.13 M -$224 K -16.6% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1.12 M -$232 K -17.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $1.01 M -$145 K -12.5% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $1.36 M +$177 K +15% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.35 M +$113 K +9.14% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.35 M +$128 K +10.4% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.16 M +$882 K +320% Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $1.18 M +$358 K +43.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.24 M +$271 K +28.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.23 M +$289 K +30.9% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $276 K +$18 K +6.98% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $821 K +$475 K +137% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $966 K +$570 K +144% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $936 K +$546 K +140% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $258 K -$136 K -34.5% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $346 K +$298 K +621% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $396 K +$352 K +800% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $390 K +$14 K +3.72% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $394 K +$351 K +816% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $48 K -$146 K -75.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $44 K -$128 K -74.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $376 K -$635 K -62.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $43 K -$21 K -32.8% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $194 K +$13 K +7.18% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $172 K +$103 K +149% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.01 M +$941 K +1344% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $64 K -$40 K -38.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $181 K +$72 K +66.1% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $69 K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $70 K Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $104 K -$245 K -70.2% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $109 K Sep 30, 2013 10-Q 2013-11-01
Q4 2012 $349 K Dec 31, 2012 10-K 2014-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.